gms | German Medical Science

70. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Skandinavischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

12.05. - 15.05.2019, Würzburg

ePoster Montag, 13.05.2019
Neurochirurgische Onkologie I/Neurosurgical oncology I

Meeting Abstract (P047)

Proliferation and tumour expansion are associated with COX2 expression but not with ASA intake

Behling F, Ries V, Skardelly M, Gepfner-Tuma I, Schuhmann M, Ebner F, Tabatabai G, Schittenhelm J, Bornemann A, Tatagiba M
Meeting Abstract (P048)

Correlation of molecular tumour markers and tumour localisation in low-grade and grade III gliomas

Knapp PG, Gempt J, Meyer H, Ketterer C, Wasmeier AM
Meeting Abstract (P049)

The CXCR2/CXCL2/CXCL8 signalling pathway in glioblastoma multiforme patients in the development of resistance

Urbantat RM, Acker G, Brandenburg S, Vajkoczy P
Meeting Abstract (P050)

Integrity of (b)lood-(o)xygen-(l)evel)-(d)ependent signal of language associated brain activation depending on tumour proximity and radiological tumour growth patterns in patients with glioblastoma

Rosengarth K, Hense K, Wiesinger I, Ott C, Doenitz C, Brawanski A, Wendl C
Meeting Abstract (P051)

Comparison of outcome parameters using 60 Hz stimulation vs. monopolar stimulation in patients operated on eloquently located glioblastoma – a retrospective monocentric study

Suresh MP, Hibbe H, Rapp M, Kamp MA, Fischer I, Sabel M
Meeting Abstract (P052)

CUSP9* elicits significant anti-cancer activity against glioblastoma cells in vitro

Halatsch ME, Kast RE, Dwucet A, Heiland T, Siegelin MD, Wirtz CR, Karpel-Massler G
Meeting Abstract (P053)

Bcl-2/Bcl-xL inhibition synergistically enhances the anti-neoplastic activity of CUSP9v3 against glioblastoma cells in vitro

Halatsch ME, Kast RE, Dwucet A, Hlavac M, Heiland T, Westhoff MA, Siegelin MD, Wirtz CR, Karpel-Massler G
Meeting Abstract (P054)

Metabolic reprogramming following a combined treatment with imipridones and 2-deoxyglucose elicits energy depletion and synergistic anti-glioblastoma activity

Pruss M, Dwucet A, Westhoff MA, Hlavac M, Siegelin MD, Wirtz CR, Halatsch ME, Karpel-Massler G
Meeting Abstract (P055)

Prognostic relevance of epilepsy at presentation in WHO grade III Glioma

Mercas BI, Heiland DH, Masalha W, Franco P, Beck J, Delev D, Schnell O
Meeting Abstract (P056)

IgG4-related hypertrophic pachymeningitis – a rare entity with elusive diagnosis

Esmaeilzadeh M, Polemikos M, Dadak M, Hartmann C, Hermann EJ, Krauss JK
Meeting Abstract (P057)

Ex vivo expanded NK cells with high cytotoxicity against cetuximab-opsonised primary glioblastoma cells

Michen S, Frosch J, Füssel M, Schackert G, Temme A
Meeting Abstract (P058)

Genome-wide methylation profiling of glioblastoma extracellular vesicle DNA allows tumour classifcation

Ricklefs FL, Maire C, Kolbe K, Holz M, Westphal M, Schüller U, Lamszus K